THE LANDSCAPE OF DRUG PERTURBATION EFFECTS IN LEUKEMIA AND LYMPHOMA
Sebastian Scheinost(German Cancer Research Center), Thorsten Zenz(Universität Ulm), Markus G. Manz(Ospedale San Giovanni Bellinzona), Beat Bornhäuser(University Children's Hospital Zurich), Wolfgang Huber(European Molecular Biology Laboratory), Jennifer Hüellein(European Molecular Biology Organization), Marta Crespo Maull(Vall d'Hebron Institut de Recerca), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Francesc Bosch(Vall d'Hebron Hospital Universitari), Thomas Kindler(German Cancer Research Center), Sascha Dietrich(European Molecular Biology Organization), Alexandre Theocharides(University of Zurich), Leopold Sellner(National Center for Tumor Diseases), Tatjana Walther(German Cancer Research Center), Lena Wagner(German Cancer Research Center), Michael W.M. Kühn(Franklin University), F. Florence Nguyen‐Khac(Sorbonne Université), Jianping Lü(China University of Geosciences (Beijing))
Cited by 0
Related Papers
Detecting differential usage of exons from RNA-seq data
|Genome Research|2012|1.6k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
|Cancer Cell|2003|927